Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) NSE

213.38

-4.71(-2.16%)

Updated at December 05 09:36AM

Currency In INR

Valuation

Market Cap14.62B
Enterprise Value13.42B
P/E Ratio23.55
PEG Ratio13.3
Price/Sales Ratio5.15
Price/Book Ratio5.77
Enterprise/Revenue5.13
Enterprise/EBITDA16.82

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.22
Operating Margin0.16

Management Effectiveness

Return On Assets0.21
Return On Equity0.27

Income Statement

Revenue2.69B
Revenue/Share42.26
Gross Profit1.72B
EBITDA510.71M
Net Income553.61M
Diluted EPS8.22

Balance Sheet

Total Cash1.59B
Total Cash/Share23.82
Total Debt88.36M
Total Debt/Equity0.03
Current Ratio6.07
Book Value Per Share37.8

Price History

52-Week Change-23.05
52-Week High301.65
52-Week Low192.85
Moving Average 50 Days215.77
Moving Average 200 Days227.79

Statistics

Average Volume82,900
Shares Outstanding66.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2.5
Trailing Annual Dividend Yield1.15
Payout Ratio0
Last Split Factor8:1
Last Split DateJuly 20, 2004